Commercialization: Page 76

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaOutlet

    In a nod to the founding fathers, several states have started a revolution against the tyranny of high margin pharmaceuticals with the uninsured elderly playing the role of constituents deprived of their rights. This time the battlefield is the U.S. courts, and lawyers representing both sides are...

    By Don Sharpe • Aug. 11, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's on your mind: Opinions

    The Time Has Come The idea of setting up a separate agency to oversee postmarketing surveillance has been proposed over the past two to three decades — perhaps now its time has come. I would endorse using a new source of user funds to establish a quasiautonomous agency separate from FDA and indus...

    By PharmaVoice Team • Aug. 11, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Raise Your Voice: Letters

    Wow! Great! Fantastic! Finally! Over the years I have been championing this message. Leave it to PharmaVOICE to give it the prominence it deserves. Great first step. Now let’s talk about how culture, language, geography, family, age, and gender can impact the understanding of healthcare instructi...

    By PharmaVoice Team • Aug. 11, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski CONTRIBUTING EDITORS Diane Hoffman Virginia Kirk Denise Myshko Kim Ribbink Deborah Ruriani Lynda Sears Copyright 2002 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Two, Num...

    By Taren Grom • Aug. 11, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Who's on the List by Section

    The Commanders & Chiefs 12 Ahsan Awan Ross Bjella Laurie Cooke, R.Ph. John Farinacci Tuan Ha-Ngoc Fred Hassan Thomas Hughes, Ph.D. Greg Johnson Rick Keefer Kyle Kennedy William Maichle John Maraganore, Ph.D. Francois Nader, M.D. Nader Naeymi-Rad Angus Russell Laurent Schockmel, DVM Jeffrey St...

    By PharmaVoice Team • July 30, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Reading List

    NON-FICTION Memo to the President: How We Can Restore America’s Reputation and Leadership • Madeleine Albright Making it all Work: Winning at the Game of Work and the Business of Life • David Allen Who Goes First?: The Story of Self-Experimentation in Medicine • Lawrence K. Altman It’s Not About ...

    By PharmaVoice Team • July 30, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Dr. Peter CARBERRY Dan DUNHAM Dr. Betsy GAROFALO Walt JOHNSTON Astellas Pharma’s U.S. Subsidiaries Name VPs Tokyo-based Astellas Pharma Inc. has announced a number of new executives at its two U.S.-based subsidiaries. Astellas Pharma Global Development (APGD) has hired Peter C...

    By PharmaVoice Team • July 29, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: GfK Announces Additions to Marketing Research Portfolio TVG Offers New Forecasting Suite QuestaWeb Offerings Reduce Costs for Importers, Exporters Skila Launches Global Market Access Management Solution StudyManag...

    By PharmaVoice Team • July 29, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    New Healthcare-related Products, Services, and Companies Featured Briefs: GfK Launches Managed Markets Practice CDM Launches Division Focused on Healthcare Branding Brandtectonics Access Establishes U.S. Office inVentiv Health Rebrands Strategy and Analytics Business GSK, Pfizer Combine HIV Asset...

    By PharmaVoice Team • July 29, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Who's on the List by Company

    Acadia Pharmaceuticals Inc. John Kaiser 68 Acorda Therapeutics Inc. Ron Cohen, M.D. 39 Alnylam Pharmaceuticals John Maraganore, Ph.D. 24 AMR Research Hussain Mooraj 107 Amylin Pharmaceuticals Joseph Martinez 76 Astellas Pharma US Charlotte Berlin 64 AVEO Pharmaceuticals Inc. Tuan Ha-Ngoc 20 Avid ...

    By PharmaVoice Team • July 29, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    The PharmaVOICE 100: 2009 PharmaVOICE is honored to bring you its fifth annual special issue celebrating 100 of the most inspiring individuals in the life-sciences industry. This issue, which is called the feel-good issue of the year, is packed with in-depth profiles showcasing the industry’s bes...

    By Taren Grom • July 29, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Alliance BUILDERS

    Susan Dorfman, Skila Karen J. Hanson, Ph.D., BioStrategy Partners Hussain Mooraj, AMR Research Dominic A. Marasco, Innovex Inc., a Quintiles companyy Bill Meisle, GlaxoSmithKline Building alliances, creating relationships, and making the right connections requires a great deal of skill and savvy,...

    By PharmaVoice Team • July 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The MENTORS

    Glen Drummond, Gilead Sciencess Daniel James Schneider, Life Science Commercialization Consultant Peter Marchesini, inVentiv Health Lawrence G. Wright, Ph.D., MedErgy HealthGroup Mentoring takes patience, foresight, and unselfish devotion to furthering the success of others. Creating a corporate ...

    By PharmaVoice Team • July 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Technologists

    Lucia (Lucy) Deus, SupplyScape Corp. Joseph A. Tetzlaff, i3 David J. Pasta, ICON Clinical Research Lucia (Lucy) Deus, SupplyScape Corp. Joseph A. Tetzlaff, i3 David J. Pasta, ICON Clinical Research Cutting-edge thinking and solutions are the hallmark of this dynamic group of individuals who are p...

    By PharmaVoice Team • July 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Brand CHAMPIONS

    As Partner and Chief Strategic Officer at Wishbone/ITP, Judy Capano sets a strong ethical example that’s inspiring to all who work with her. Judy Capano was a Director of Client Services before she turned 30. Problem-Solver • Grounded Name: Judy Capano Current Position: Partner and Chief Strategi...

    By PharmaVoice Team • July 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The ENTREPRENEURS

    Michael Beckloff, Beckloff Associates Dr. Joan Bradley, The JB Ashtin Group Faruk Capan, Intouch Solutions Gary Beer, DOV Pharmaceutical, Inc. Ron Cohen, Acorda Therapeutics Inc. Elizabeth Apelles, Greater than One Jaswinder Chadha, marketRx Denise Deman-Williams, Bench International Jay Deakins,...

    By PharmaVoice Team • July 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Kurt HARTMAN Dr. Craig HOPKINSON New Hires at Eisai Eisai Inc., a U.S. pharmaceuti cal subsidiary of Japan’s Eisai Co. Ltd., has appointed Kurt Hart man, J.D., senior director of value and access, with responsibility for integrating and aligning Eisai’s focus on reimbursement ...

    By PharmaVoice Team • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    Symyx Grants ACCESS TO MOLECULE INFORMATION The Biotechnology Industry Organization (BIO) has launched the BIO Community (community.convention.bio.org) to provide free resources to biotechnology leaders and professionals in an effort to help them overcome the chal lenges currently facing the indu...

    By PharmaVoice Team • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    Vincent Aurentz, executive VP of portfolio devel opment, says this activity complements the compa ny’s tool kit of collaborative approaches to build a highquality portfolio with partners. “The creation of a venture capital fund under lines our commitment to be a best partner for biotech entrepren...

    By PharmaVoice Team • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Pharma R&D Spending Remains Robust Despite Tough Economy Despite the current economic downturn, pharmaceutical research and development spending continues to play a vital role in the pharmaceutical industry. According to a recent report by CBR Pharma Insights, recent trends indicate a consoli...

    By PharmaVoice Team • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Manufacturer Windfall Rebates: Change on the Horizon

    The transfer of drug coverage for the dual eligible beneficiaries from Medicaid to Medicare Part D has come under scrutiny by Congress for alleged profit windfalls for manufacturers. The implications of the windfall issue for the pharmaceutical industry are vast. Manufacturers with a large Medica...

    By Matthew Warburton and Carleen Kelly • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    "Obamaceuticals:" The Good, The Bad, The Controversial, and the Undecided

    According to the Deloitte 2009 Industry Outlook report published in December 2008, the Obama Administration could make more changes to the nation’s healthcare system than have occurred since the 1960s. While there are many government policy changes proposed, PharmaVOICE asked leaders from all seg...

    By PharmaVoice Team • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    David Brennan: Into the Future

    BY KIM RIBBINK Into the FUTURE In April, the Pharmaceutical Research and Manufacturers of America (PhRMA) elected AstraZeneca CEO David Brennan as its new chairman, a choice that bodes well for the future of health care and the pharmaceutical companies the organization represents. In his more tha...

    By PharmaVoice Team • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Mastering Multichannel Marketing

    BY ROBIN ROBINSON KEY TO SUCCESS:Match up channel properties and consistent content with consumer preferences. The key to successful multichannel marketing is to be wherever the consumer is when he or she is ready to receive your message. Easy, right? Not a chance, especially when the consumer is...

    By Robin Robinson • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Could the tide be turning? The bad and the good We know we are operating in a new economic frontier, when bad news actually passes for good news. A recently released IMS report states that the value of the global pharmaceutical market is expected to grow 2.5% to 3.5% on a constant-dollar basis in...

    By Taren Grom • May 23, 2009